Befesa S.A.

  • WKN: A2H5Z1
  • ISIN: LU1704650164
  • Land: Luxemburg

Nachricht vom 21.06.2021 | 13:00

Befesa S.A.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Befesa S.A.
21.06.2021 / 13:00
Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

/

NOTIFICATION OF MAJOR HOLDINGS

Release according to Article 40, Section 1 of the German Securities Trading Act (Wertpapierhandelsgesetz - WpHG) and Art. 11 (6) of the Transparency Law dated
11 January 2008 of the Grand Duchy of Luxembourg (the Transparency Law) with the objective of Europe-wide distribution

Befesa S.A.
21 June 2021

1. Details of the Issuer:
Befesa S.A.
46, Boulevard Grande-Duchesse Charlotte L-1330 Luxembourg
Grand Duchy of Luxembourg
2. Reason for the notification:
An acquisition or disposal of voting rights
3. Details of person subject to the notification obligation:
INDUMENTA PUERI, S.L., Malaga, Spain
4. Full name of shareholder(s) (if different from 3.):
Global Portfolio Investments, S.L. (B-92709419)
5. Date on which the threshold was crossed or reached:
17 June 2021
6. Total positions of person(s) subject to the notification obligation (Art. 8 and 9 of the Transparency Law):
  % of voting rights attached to shares (total of 7.A) % of voting rights through financial instruments
(total of 7.B.1 + 7.B.2)
Total of both in % (7.A + 7.B) Total number of voting rights of issuer
Resulting situation on the date on which threshold was
crossed or reached
5.41% 0.00% 5.41% 39,999,998
Position of previous notification (if

applicable)
       
 
7. Notified details of the resulting situation on the date on which the threshold was crossed or reached:
A: Voting rights attached to shares
Class/type of shares
ISIN code (if possible)
Number of voting rights % of voting rights
Direct
(Art 8 of the Transparency Law)
Indirect
(Art 9 of the Transparency Law)
Direct

(Art 8 of the Transparency Law)
Indirect
(Art 9 of the Transparency Law)
ISIN LU1704650164   2,167,670   5.41%
SUBTOTAL A
(Direct & Indirect)
2,167,670 5.41%
 
Type of financial instrument Expiration date Exercise/
Conversion Period
Number of voting rights that may be acquired if the instrument is exercised/converted % of voting rights
         
    Subtotal B 1   %
 

 

Type of financial instrument Expiration date Exercise/
Conversion Period
Physical or cash settlement Number of voting rights % of voting rights
           
      Subtotal B 2   %
 
  Name-   % of voting rights Total of both  
% of voting rights through financial  
held by ultimate Instruments held  
controlling person by ultimate Directly
or entity or held controlling person controlled
directly by any or entity or held by (use
subsidiary if it directly by any number(s)
equals or is subsidiary if it from 1st
higher than the equals or is column)
notifiable higher than the  
threshold notifiable  
  threshold  
  Indumenta Pueri, S.L. 5.41% -% 5.41%  
  Global Portfolio Investments, S.L. 5.41% -% 5.41%  
 

 

Company information

Company: Befesa S.A.
46, Boulevard Grande-Duchesse Charlotte L-1330 Luxembourg
Grand Duchy of Luxembourg

LEI: 222100VXGA8L6J4ZWG61
ISIN: LU1704650164

Contact: Rafael Pérez
Email: irbefesa@befesa.com
Internet: www.befesa.com



21.06.2021 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Allianz SE: Allianz kündigt Abschluss eines Rückversicherungsvertrages in den USA an

03. Dezember 2021, 07:03

Aktueller Webcast

Deutsche Konsum REIT-AG

FY 2020/2021 Financial Results

16. Dezember 2021

Aktuelle Research-Studie

CEWE Stiftung & Co. KGaA

Original-Research: CEWE Stiftung & Co. KGaA (von GSC Research GmbH): Kaufen

02. Dezember 2021